USP13 promotes enzalutamide resistance by catalyzing depolyubiquitination of PCMT1 in prostate cancer. - Wang Z; Liu X; Li Z; Yuan R; Zheng F; Xiong S; Zeng J; Pang W; Fu B; Li S; Xu S; Deng J (Cell death & disease, 2026)